E
HAE icon

Ergoteles’s Haemonetics HAE Stock Holding History

Ergoteles’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,634
Closed -$991K – 388
2023
Q2 		$991K Buy
+11,634
New +$984K 0.05% 468
2023
Q1 		– Sell
-12,180
Closed -$958K – 1447
2022
Q4 		$958K Buy
12,180
+2,153
+21% +$173K 0.04% 473
2022
Q3 		$742K Buy
+10,027
New +$720K 0.03% 609
2021
Q1 		– Sell
-2,000
Closed -$238K – 906
2020
Q4 		$238K Buy
+2,000
New +$215K 0.01% 570

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return